Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Buy
752
+54
+8% +$19.3K 0.16% 110
2025
Q4
$229K Sell
698
-198
-22% -$62.8K 0.14% 126
2025
Q3
$253K Buy
896
+65
+8% +$18.9K 0.16% 113
2025
Q2
$232K Buy
831
+67
+9% +$19K 0.16% 120
2025
Q1
$238K Sell
764
-87
-10% -$25.7K 0.19% 115
2024
Q4
$222K Sell
851
-277
-25% -$82.2K 0.16% 132
2024
Q3
$364K Sell
1,128
-16
-1% -$5.23K 0.27% 82
2024
Q2
$357K Buy
1,144
+65
+6% +$19.1K 0.29% 83
2024
Q1
$307K Sell
1,079
-111
-9% -$32.5K 0.28% 87
2023
Q4
$343K Buy
+1,190
New +$324K 0.4% 57

Other funds holding AMGN

M3 Advisory Group's AMGN Position: Q1 2026 in Review

M3 Advisory Group increased its Amgen (AMGN) stake by 7.7% in Q1 2026, buying an estimated $19.3K and bringing the position to 752 shares worth $265K. The position accounts for 0.16% of the portfolio, ranked #110.

M3 Advisory Group first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $364K in Q3 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • M3 Advisory Group held 752 shares of Amgen worth $265K as of Q1 2026.
  • M3 Advisory Group bought 54 Amgen shares in Q1 2026, an estimated $19.3K.
  • Amgen made up 0.16% of M3 Advisory Group's portfolio in Q1 2026, its #110 holding.
  • M3 Advisory Group first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • M3 Advisory Group's Amgen position peaked at $364K in Q3 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on M3 Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.